StockVS

RELX PLC (RELX) Stock Analysis

Industrials

RELX PLC

$32.90

$-0.11 (-0.33%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

RELX PLC functions as a global provider of information-based analytics and decision tools, serving professional and business customers across North America, Europe, and international markets through its Risk, Scientific, Technical & Medical, Legal, and Exhibitions segments. The company operates within the Industrials sector, specifically within the Specialty Business Services industry, which characterizes its focus on specialized professional services rather than broad consumer goods or heavy manufacturing. With a market capitalization of $57.49B, an annual revenue of $9.59B, and an employee count of 35720, RELX PLC maintains a substantial scale that positions it as a major entity within its niche. These valuation and revenue figures indicate that the company commands a significant market presence, reflecting deep penetration in its specialized sectors and the high value placed on its intellectual property and service infrastructure by the global market.

Financial Health

The company reported a total revenue of $9.59B over the trailing twelve months, generating a net income of $2.06B and an EBITDA of $3.20B. The substantial gap between the $9.59B revenue and the $2.06B net income reveals a robust cost structure where operating expenses, including cost of goods sold and administrative costs, absorb approximately 78.5% of total revenue before reaching the bottom line. Free cash flow stands at $2.16B, which signifies strong financial flexibility allowing the company to fund capital expenditures, reduce debt, or return value to shareholders without relying on external financing. Profitability is supported by a gross margin of 66.3%, indicating high pricing power and efficient production or service delivery costs relative to sales. Operating margin is recorded at 31.4%, demonstrating effective control over overhead and operational expenses, while the profit margin of 21.5% confirms that the company retains a healthy portion of every dollar earned as actual profit. The balance sheet shows a cash position of $131.00M against total debt of $7.27B, resulting in a debt-to-equity ratio of 304.06, which suggests a highly leveraged capital structure where liabilities significantly exceed equity holdings. Despite the high leverage, the current ratio of 0.49 indicates that current assets are less than current liabilities, pointing to potential short-term liquidity constraints that require careful management of working capital. Return on Equity reaches 70.5%, highlighting exceptional efficiency in generating profits from shareholder investments, while Return on Assets stands at 12.5%, showing effective utilization of the asset base to generate earnings.

Valuation Assessment

The trailing twelve-month P/E ratio is 21.31, while the forward P/E is 14.71, implying that the market expects earnings to grow significantly in the future to justify the current multiple compression relative to historical averages. The price-to-book ratio of 18.53 indicates that the market values the company at a substantial premium over its tangible book value, reflecting the high value placed on its intangible assets, brand strength, and future earning potential. Alternative valuation metrics such as the price-to-sales ratio of 5.99 and an EV/EBITDA of 20.39 suggest that investors are willing to pay a high multiple for revenue and earnings, consistent with the company's dominant position and stable cash generation. The stock has traded between a 52-week high of $56.33 and a 52-week low of $27.57, with the current price trading at a level that reflects recent market consolidation but remains well below the yearly peak. A beta of 0.20 indicates that the stock exhibits very low volatility relative to the broader market, moving less than a fifth of the magnitude of the overall market index during typical market swings.

Growth & Income

Revenue growth is recorded at 1.2% year-over-year, while earnings growth is significantly higher at 17.0% year-over-year. This divergence implies that the company is improving its profit margins or benefiting from cost synergies, allowing net income to expand at a much faster rate than top-line sales. As a dividend payer, RELX PLC offers a dividend yield of 2.9% with a payout ratio of 57.4%, suggesting that the current dividend is sustainable given the strong earnings growth and high profit margins. The payout ratio leaves ample room for dividend increases if earnings continue to outpace revenue growth in subsequent periods. Overall, the company presents a profile of moderate revenue expansion coupled with accelerated earnings growth and a consistent commitment to returning capital to shareholders through dividends.

Peer Comparison

RELX PLC (RELX) operates in the Specialty Business Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
RELX PLC RELX $58.35B 21.9
Cintas Corporation CTAS $68.46B 36.1
Thomson Reuters Corporation TRI.TO $50.46B 24.1
Thomson Reuters Corporation TRI $36.55B 24.1

The Specialty Business Services industry average P/E ratio is 65.9x. RELX PLC trades at a P/E of 21.9.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About RELX PLC

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Visit website →

Key Statistics

Market Cap
$58.35B
P/E Ratio
21.86
52-Week High
$56.33
52-Week Low
$27.57
Avg Volume
3.20M
Beta
0.26
Dividend Yield
2.79%

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United Kingdom
Employees
35,720